{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:37:50Z","timestamp":1790231870117,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sirtuin 3 (SIRT3) is the main mitochondrial deacetylase. SIRT3 regulates cell metabolism and redox homeostasis, and protects from aging and age-associated pathologies. SIRT3 may drive both oncogenic and tumor-suppressive effects. SIRT3 deficiency has been reported to promote chronic inflammation-related disorders, but whether SIRT3 impacts on innate immune responses and host defenses against infections remains essentially unknown. This aspect is of primary importance considering the great interest in developing SIRT3-targeted therapies. Using SIRT3 knockout mice, we show that SIRT3 deficiency does not affect immune cell development and microbial ligand-induced proliferation and cytokine production by splenocytes, macrophages and dendritic cells. Going well along with these observations, SIRT3 deficiency has no major impact on cytokine production, bacterial burden and survival of mice subjected to endotoxemia, <jats:italic>Escherichia coli<\/jats:italic> peritonitis, <jats:italic>Klebsiella pneumoniae<\/jats:italic> pneumonia, listeriosis and candidiasis of diverse severity. These data suggest that SIRT3 is not critical to fight infections and support the safety of SIRT3-directed therapies based on SIRT3 activators or inhibitors for treating metabolic, oncologic and neurodegenerative diseases without putting patients at risk of infection.<\/jats:p>","DOI":"10.1038\/s41598-017-04263-x","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T09:45:53Z","timestamp":1497433553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Sirtuin 3 deficiency does not alter host defenses against bacterial and fungal infections"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4614-0191","authenticated-orcid":false,"given":"Eleonora","family":"Ciarlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tytti","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1178-2752","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Lugrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Acha-Orbea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Le Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Auwerx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-0109","authenticated-orcid":false,"given":"Thierry","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"4263_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","volume":"4","author":"A Savva","year":"2013","unstructured":"Savva, A. & Roger, T. Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol \n                           4, 387, doi:10.3389\/fimmu.2013.00387 (2013).","journal-title":"Front Immunol"},{"key":"4263_CR2","doi-asserted-by":"publisher","first-page":"15456","DOI":"10.1021\/bi011858j","volume":"40","author":"AA Sauve","year":"2001","unstructured":"Sauve, A. A. et al. Chemistry of gene silencing: the mechanism of NAD+ -dependent deacetylation reactions. Biochemistry \n                           40, 15456\u201315463 (2001).","journal-title":"Biochemistry"},{"key":"4263_CR3","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1038\/ncomms3327","volume":"4","author":"D Rauh","year":"2013","unstructured":"Rauh, D. et al. An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms. Nat Commun \n                           4, 2327, doi:10.1038\/ncomms3327 (2013).","journal-title":"Nat Commun"},{"key":"4263_CR4","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1128\/MCB.01636-07","volume":"27","author":"DB Lombard","year":"2007","unstructured":"Lombard, D. B. et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol \n                           27, 8807\u20138814, doi:10.1128\/MCB.01636-07 (2007).","journal-title":"Mol Cell Biol"},{"key":"4263_CR5","doi-asserted-by":"publisher","unstructured":"Yang, W. et al. Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization. Cell \n                           167, 985\u20131000 e1021, doi:10.1016\/j.cell.2016.10.016 (2016).","DOI":"10.1016\/j.cell.2016.10.016"},{"key":"4263_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.metabol.2011.09.016","volume":"61","author":"BJ Gurd","year":"2012","unstructured":"Gurd, B. J., Holloway, G. P., Yoshida, Y. & Bonen, A. In mammalian muscle, SIRT3 is present in mitochondria and not in the nucleus; and SIRT3 is upregulated by chronic muscle contraction in an adenosine monophosphate-activated protein kinase-independent manner. Metabolism \n                           61, 733\u2013741, doi:10.1016\/j.metabol.2011.09.016 (2012).","journal-title":"Metabolism"},{"key":"4263_CR7","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1128\/MCB.00822-12","volume":"32","author":"T Iwahara","year":"2012","unstructured":"Iwahara, T., Bonasio, R., Narendra, V. & Reinberg, D. SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol Cell Biol \n                           32, 5022\u20135034, doi:10.1128\/MCB.00822-12 (2012).","journal-title":"Mol Cell Biol"},{"key":"4263_CR8","doi-asserted-by":"publisher","first-page":"1243417","DOI":"10.1126\/science.1243417","volume":"342","author":"CB Peek","year":"2013","unstructured":"Peek, C. B. et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science \n                           342, 1243417, doi:10.1126\/science.1243417 (2013).","journal-title":"Science"},{"key":"4263_CR9","doi-asserted-by":"publisher","first-page":"13560","DOI":"10.1074\/jbc.M414670200","volume":"280","author":"T Shi","year":"2005","unstructured":"Shi, T., Wang, F., Stieren, E. & Tong, Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem \n                           280, 13560\u201313567, doi:10.1074\/jbc.M414670200 (2005).","journal-title":"J Biol Chem"},{"key":"4263_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.molcel.2011.01.002","volume":"41","author":"WC Hallows","year":"2011","unstructured":"Hallows, W. C. et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell \n                           41, 139\u2013149, doi:10.1016\/j.molcel.2011.01.002 (2011).","journal-title":"Mol Cell"},{"key":"4263_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature08778","volume":"464","author":"MD Hirschey","year":"2010","unstructured":"Hirschey, M. D. et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature \n                           464, 121\u2013125, doi:10.1038\/nature08778 (2010).","journal-title":"Nature"},{"key":"4263_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cmet.2010.11.003","volume":"12","author":"T Shimazu","year":"2010","unstructured":"Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab \n                           12, 654\u2013661, doi:10.1016\/j.cmet.2010.11.003 (2010).","journal-title":"Cell Metab"},{"key":"4263_CR13","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.2337\/db12-1650","volume":"62","author":"E Jing","year":"2013","unstructured":"Jing, E. et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes \n                           62, 3404\u20133417, doi:10.2337\/db12-1650 (2013).","journal-title":"Diabetes"},{"key":"4263_CR14","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1074\/jbc.M115.702076","volume":"291","author":"W Yu","year":"2016","unstructured":"Yu, W. et al. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. J Biol Chem \n                           291, 3268\u20133279, doi:10.1074\/jbc.M115.702076 (2016).","journal-title":"J Biol Chem"},{"key":"4263_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","volume":"143","author":"S Someya","year":"2010","unstructured":"Someya, S. et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell \n                           143, 802\u2013812, doi:10.1016\/j.cell.2010.10.002 (2010).","journal-title":"Cell"},{"key":"4263_CR16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.exger.2012.08.007","volume":"48","author":"AS Bause","year":"2013","unstructured":"Bause, A. S. & Haigis, M. C. SIRT3 regulation of mitochondrial oxidative stress. Exp Gerontol \n                           48, 634\u2013639, doi:10.1016\/j.exger.2012.08.007 (2013).","journal-title":"Exp Gerontol"},{"key":"4263_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11357-013-9559-2","volume":"36","author":"D Albani","year":"2014","unstructured":"Albani, D. et al. Modulation of human longevity by SIRT3 single nucleotide polymorphisms in the prospective study \u201cTreviso Longeva (TRELONG)\u201d. Age (Dordr) \n                           36, 469\u2013478, doi:10.1007\/s11357-013-9559-2 (2014).","journal-title":"Age (Dordr)"},{"key":"4263_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ygeno.2004.11.003","volume":"85","author":"D Bellizzi","year":"2005","unstructured":"Bellizzi, D. et al. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics \n                           85, 258\u2013263, doi:10.1016\/j.ygeno.2004.11.003 (2005).","journal-title":"Genomics"},{"key":"4263_CR19","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/ejhg.2009.54","volume":"17","author":"F Lescai","year":"2009","unstructured":"Lescai, F. et al. Human longevity and 11p15.5: a study in 1321 centenarians. Eur J Hum Genet \n                           17, 1515\u20131519, doi:10.1038\/ejhg.2009.54 (2009).","journal-title":"Eur J Hum Genet"},{"key":"4263_CR20","doi-asserted-by":"publisher","first-page":"e115616","DOI":"10.1371\/journal.pone.0115616","volume":"9","author":"MJ TenNapel","year":"2014","unstructured":"TenNapel, M. J. et al. SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohort. PLoS One \n                           9, e115616, doi:10.1371\/journal.pone.0115616 (2014).","journal-title":"PLoS One"},{"key":"4263_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fcvm.2016.00038","volume":"3","author":"C Koentges","year":"2016","unstructured":"Koentges, C. & Bode, C. & Bugger, H. SIRT3 in Cardiac Physiology and Disease. Front Cardiovasc Med \n                           3, 38, doi:10.3389\/fcvm.2016.00038 (2016).","journal-title":"Front Cardiovasc Med"},{"key":"4263_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijcard.2016.06.236","volume":"220","author":"Y Lu","year":"2016","unstructured":"Lu, Y. et al. SIRT3 in cardiovascular diseases: Emerging roles and therapeutic implications. Int J Cardiol \n                           220, 700\u2013705, doi:10.1016\/j.ijcard.2016.06.236 (2016).","journal-title":"Int J Cardiol"},{"key":"4263_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.tem.2015.06.001","volume":"26","author":"E McDonnell","year":"2015","unstructured":"McDonnell, E., Peterson, B. S., Bomze, H. M. & Hirschey, M. D. SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol Metab \n                           26, 486\u2013492, doi:10.1016\/j.tem.2015.06.001 (2015).","journal-title":"Trends Endocrinol Metab"},{"key":"4263_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbcan.2011.04.004","volume":"1816","author":"TY Alhazzazi","year":"2011","unstructured":"Alhazzazi, T. Y., Kamarajan, P., Verdin, E. & Kapila, Y. L. SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta \n                           1816, 80\u201388, doi:10.1016\/j.bbcan.2011.04.004 (2011).","journal-title":"Biochim Biophys Acta"},{"key":"4263_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s11064-014-1507-8","volume":"40","author":"L Liu","year":"2015","unstructured":"Liu, L., Peritore, C., Ginsberg, J., Kayhan, M. & Donmez, G. SIRT3 attenuates MPTP-induced nigrostriatal degeneration via enhancing mitochondrial antioxidant capacity. Neurochem Res \n                           40, 600\u2013608, doi:10.1007\/s11064-014-1507-8 (2015).","journal-title":"Neurochem Res"},{"key":"4263_CR26","doi-asserted-by":"publisher","first-page":"e48225","DOI":"10.1371\/journal.pone.0048225","volume":"7","author":"HJ Weir","year":"2012","unstructured":"Weir, H. J. et al. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer\u2019s disease. PLoS One \n                           7, e48225, doi:10.1371\/journal.pone.0048225 (2012).","journal-title":"PLoS One"},{"key":"4263_CR27","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s11064-015-1630-1","volume":"40","author":"W Yang","year":"2015","unstructured":"Yang, W. et al. Mitochondrial Sirt3 Expression is Decreased in APP\/PS1 Double Transgenic Mouse Model of Alzheimer\u2019s Disease. Neurochem Res \n                           40, 1576\u20131582, doi:10.1007\/s11064-015-1630-1 (2015).","journal-title":"Neurochem Res"},{"key":"4263_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrc3985","volume":"15","author":"A Chalkiadaki","year":"2015","unstructured":"Chalkiadaki, A. & Guarente, L. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer \n                           15, 608\u2013624, doi:10.1038\/nrc3985 (2015).","journal-title":"Nat Rev Cancer"},{"key":"4263_CR29","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1096\/fj.14-268409","volume":"29","author":"UH Beier","year":"2015","unstructured":"Beier, U. H. et al. Essential role of mitochondrial energy metabolism in Foxp3(+) T-regulatory cell function and allograft survival. FASEB J \n                           29, 2315\u20132326, doi:10.1096\/fj.14-268409 (2015).","journal-title":"FASEB J"},{"key":"4263_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.10.021","author":"W Yu","year":"2016","unstructured":"Yu, W. et al. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy. Biochim Biophys Acta. doi:10.1016\/j.bbadis.2016.10.021 (2016).","journal-title":"Biochim Biophys Acta"},{"key":"4263_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2015.12.037","volume":"472","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Deacetylation of MnSOD by PARP-regulated SIRT3 protects retinal capillary endothelial cells from hyperglycemia-induced damage. Biochem Biophys Res Commun \n                           472, 425\u2013431, doi:10.1016\/j.bbrc.2015.12.037 (2016).","journal-title":"Biochem Biophys Res Commun"},{"key":"4263_CR32","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.2337\/db14-1810","volume":"64","author":"L Lantier","year":"2015","unstructured":"Lantier, L. et al. SIRT3 Is Crucial for Maintaining Skeletal Muscle Insulin Action and Protects Against Severe Insulin Resistance in High-Fat-Fed Mice. Diabetes \n                           64, 3081\u20133092, doi:10.2337\/db14-1810 (2015).","journal-title":"Diabetes"},{"key":"4263_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI77632","volume":"125","author":"M Morigi","year":"2015","unstructured":"Morigi, M. et al. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest \n                           125, 715\u2013726, doi:10.1172\/JCI77632 (2015).","journal-title":"J Clin Invest"},{"key":"4263_CR34","doi-asserted-by":"publisher","first-page":"33201","DOI":"10.1038\/srep33201","volume":"6","author":"WY Zhao","year":"2016","unstructured":"Zhao, W. Y., Zhang, L., Sui, M. X., Zhu, Y. H. & Zeng, L. Protective effects of sirtuin 3 in a murine model of sepsis-induced acute kidney injury. Sci Rep \n                           6, 33201, doi:10.1038\/srep33201 (2016).","journal-title":"Sci Rep"},{"key":"4263_CR35","doi-asserted-by":"publisher","unstructured":"Akamata, K. et al. SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis. Oncotarget, doi:10.18632\/oncotarget.12504 (2016).","DOI":"10.18632\/oncotarget.12504"},{"key":"4263_CR36","doi-asserted-by":"publisher","unstructured":"Bindu, S. et al. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage. Am J Physiol Lung Cell Mol Physiol, ajplung 00188 02016, doi:10.1152\/ajplung.00188.2016 (2016).","DOI":"10.1152\/ajplung.00188.2016"},{"key":"4263_CR37","doi-asserted-by":"publisher","unstructured":"Sosulski, M. L., Gongora, R., Feghali-Bostwick, C., Lasky, J. A. & Sanchez, C. G. Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis. J Gerontol A Biol Sci Med Sci, doi:10.1093\/gerona\/glw151 (2016).","DOI":"10.1093\/gerona\/glw151"},{"key":"4263_CR38","doi-asserted-by":"publisher","first-page":"20931","DOI":"10.1038\/srep20931","volume":"6","author":"H Zeng","year":"2016","unstructured":"Zeng, H. et al. LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3\/angiopoietins\/Tie-2 and HIF-2alpha\/Notch3 pathways. Sci Rep \n                           6, 20931, doi:10.1038\/srep20931 (2016).","journal-title":"Sci Rep"},{"key":"4263_CR39","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.1038\/cddis.2014.14","volume":"5","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis \n                           5, e1047, doi:10.1038\/cddis.2014.14 (2014).","journal-title":"Cell Death Dis"},{"key":"4263_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/biof.1032","volume":"38","author":"JM Villalba","year":"2012","unstructured":"Villalba, J. M. & Alcain, F. J. Sirtuin activators and inhibitors. Biofactors \n                           38, 349\u2013359, doi:10.1002\/biof.1032 (2012).","journal-title":"Biofactors"},{"key":"4263_CR41","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1074\/jbc.M114.566349","volume":"290","author":"TF Liu","year":"2015","unstructured":"Liu, T. F. et al. Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J Biol Chem \n                           290, 396\u2013408, doi:10.1074\/jbc.M114.566349 (2015).","journal-title":"J Biol Chem"},{"key":"4263_CR42","doi-asserted-by":"publisher","first-page":"e0150961","DOI":"10.1371\/journal.pone.0150961","volume":"11","author":"JH Ren","year":"2016","unstructured":"Ren, J. H. et al. Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression. PLoS One \n                           11, e0150961, doi:10.1371\/journal.pone.0150961 (2016).","journal-title":"PLoS One"},{"key":"4263_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/srep00425","volume":"2","author":"PJ Fernandez-Marcos","year":"2012","unstructured":"Fernandez-Marcos, P. J. et al. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci Rep \n                           2, 425, doi:10.1038\/srep00425 (2012).","journal-title":"Sci Rep"},{"key":"4263_CR44","doi-asserted-by":"publisher","first-page":"37944","DOI":"10.1038\/srep37944","volume":"6","author":"E Ciarlo","year":"2016","unstructured":"Ciarlo, E. et al. Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo. Sci Rep \n                           6, 37944, doi:10.1038\/srep37944 (2016).","journal-title":"Sci Rep"},{"key":"4263_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-4939-3667-0_21","volume":"1436","author":"E Ciarlo","year":"2016","unstructured":"Ciarlo, E. & Roger, T. Screening the Impact of Sirtuin Inhibitors on Inflammatory and Innate Immune Responses of Macrophages and in a Mouse Model of Endotoxic Shock. Methods Mol Biol \n                           1436, 313\u2013334, doi:10.1007\/978-1-4939-3667-0_21 (2016).","journal-title":"Methods Mol Biol"},{"key":"4263_CR46","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/infdis\/jir553","volume":"204","author":"M Mombelli","year":"2011","unstructured":"Mombelli, M. et al. Histone deacetylase inhibitors impair antibacterial defenses of macrophages. J Infect Dis \n                           204, 1367\u20131374, doi:10.1093\/infdis\/jir553 (2011).","journal-title":"J Infect Dis"},{"key":"4263_CR47","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1073\/pnas.0808146106","volume":"106","author":"T Roger","year":"2009","unstructured":"Roger, T. et al. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA \n                           106, 2348\u20132352, doi:10.1073\/pnas.0808146106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"4263_CR48","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1073\/pnas.1514018113","volume":"113","author":"T Roger","year":"2016","unstructured":"Roger, T. et al. High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates. Proc Natl Acad Sci USA \n                           113, E997\u20131005, doi:10.1073\/pnas.1514018113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"4263_CR49","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.1520727113","volume":"113","author":"A Savva","year":"2016","unstructured":"Savva, A. et al. Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis. Proc Natl Acad Sci USA \n                           113, 3597\u20133602, doi:10.1073\/pnas.1520727113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"4263_CR50","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1002\/eji.200737357","volume":"37","author":"T Roger","year":"2007","unstructured":"Roger, T., Ding, X., Chanson, A. L., Renner, P. & Calandra, T. Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression. Eur J Immunol \n                           37, 3509\u20133521, doi:10.1002\/eji.200737357 (2007).","journal-title":"Eur J Immunol"},{"key":"4263_CR51","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2010-05-284711","volume":"117","author":"T Roger","year":"2011","unstructured":"Roger, T. et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood \n                           117, 1205\u20131217, doi:10.1182\/blood-2010-05-284711 (2011).","journal-title":"Blood"},{"key":"4263_CR52","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1128\/IAI.00076-11","volume":"79","author":"E Giannoni","year":"2011","unstructured":"Giannoni, E. et al. Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns. Infect Immun \n                           79, 2690\u20132698, doi:10.1128\/IAI.00076-11 (2011).","journal-title":"Infect Immun"},{"key":"4263_CR53","doi-asserted-by":"publisher","first-page":"32483","DOI":"10.1074\/jbc.M109.014589","volume":"284","author":"C Piette","year":"2009","unstructured":"Piette, C. et al. The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem \n                           284, 32483\u201332492, doi:10.1074\/jbc.M109.014589 (2009).","journal-title":"J Biol Chem"},{"key":"4263_CR54","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.bbamcr.2009.09.007","volume":"1793","author":"J Lugrin","year":"2009","unstructured":"Lugrin, J. et al. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation. Biochim Biophys Acta \n                           1793, 1749\u20131758, doi:10.1016\/j.bbamcr.2009.09.007 (2009).","journal-title":"Biochim Biophys Acta"},{"key":"4263_CR55","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1084\/jem.20140039","volume":"211","author":"M Perreau","year":"2014","unstructured":"Perreau, M. et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med \n                           211, 2033\u20132045, doi:10.1084\/jem.20140039 (2014).","journal-title":"J Exp Med"},{"key":"4263_CR56","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.bbamcr.2013.03.004","volume":"1833","author":"J Lugrin","year":"2013","unstructured":"Lugrin, J. et al. The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock. Biochim Biophys Acta \n                           1833, 1498\u20131510, doi:10.1016\/j.bbamcr.2013.03.004 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"4263_CR57","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/15287394.2015.1051201","volume":"78","author":"G Vacher","year":"2015","unstructured":"Vacher, G. et al. Innate Immune Sensing of Fusarium culmorum by Mouse Dendritic Cells. J Toxicol Environ Health A \n                           78, 871\u2013885, doi:10.1080\/15287394.2015.1051201 (2015).","journal-title":"J Toxicol Environ Health A"},{"key":"4263_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/infdis\/jis673","volume":"207","author":"T Roger","year":"2013","unstructured":"Roger, T. et al. Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis. J Infect Dis \n                           207, 331\u2013339, doi:10.1093\/infdis\/jis673 (2013).","journal-title":"J Infect Dis"},{"key":"4263_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","volume":"213","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J Exp Med \n                           213, 15\u201323, doi:10.1084\/jem.20151570 (2016).","journal-title":"J Exp Med"},{"key":"4263_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20120030","volume":"444","author":"A Giralt","year":"2012","unstructured":"Giralt, A. & Villarroya, F. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J \n                           444, 1\u201310, doi:10.1042\/BJ20120030 (2012).","journal-title":"Biochem J"},{"key":"4263_CR61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1210\/me.2015-1301","volume":"30","author":"H Xu","year":"2016","unstructured":"Xu, H., Hertzel, A. V., Steen, K. A. & Bernlohr, D. A. Loss of Fatty Acid Binding Protein 4\/aP2 Reduces Macrophage Inflammation Through Activation of SIRT3. Mol Endocrinol \n                           30, 325\u2013334, doi:10.1210\/me.2015-1301 (2016).","journal-title":"Mol Endocrinol"},{"key":"4263_CR62","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/JCI39162","volume":"119","author":"NR Sundaresan","year":"2009","unstructured":"Sundaresan, N. R. et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest \n                           119, 2758\u20132771, doi:10.1172\/JCI39162 (2009).","journal-title":"J Clin Invest"},{"key":"4263_CR63","doi-asserted-by":"publisher","first-page":"e0124744","DOI":"10.1371\/journal.pone.0124744","volume":"10","author":"M Kim","year":"2015","unstructured":"Kim, M. et al. SIRT3 Overexpression Attenuates Palmitate-Induced Pancreatic beta-Cell Dysfunction. PLoS One \n                           10, e0124744, doi:10.1371\/journal.pone.0124744 (2015).","journal-title":"PLoS One"},{"key":"4263_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00395-013-0399-0","volume":"109","author":"S Winnik","year":"2014","unstructured":"Winnik, S. et al. Deletion of Sirt3 does not affect atherosclerosis but accelerates weight gain and impairs rapid metabolic adaptation in LDL receptor knockout mice: implications for cardiovascular risk factor development. Basic Res Cardiol \n                           109, 399, doi:10.1007\/s00395-013-0399-0 (2014).","journal-title":"Basic Res Cardiol"},{"key":"4263_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000354382","volume":"60","author":"DB Lombard","year":"2014","unstructured":"Lombard, D. B. & Zwaans, B. M. SIRT3: as simple as it seems? Gerontology \n                           60, 56\u201364, doi:10.1159\/000354382 (2014).","journal-title":"Gerontology"},{"key":"4263_CR66","first-page":"531","volume":"34","author":"G Lopalco","year":"2016","unstructured":"Lopalco, G. et al. Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders. Clin Exp Rheumatol \n                           34, 531\u2013538 (2016).","journal-title":"Clin Exp Rheumatol"},{"key":"4263_CR67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/14740338.2015.1009036","volume":"14","author":"G Murdaca","year":"2015","unstructured":"Murdaca, G. et al. Infection risk associated with anti-TNF-alpha agents: a review. Expert Opin Drug Saf \n                           14, 571\u2013582, doi:10.1517\/14740338.2015.1009036 (2015).","journal-title":"Expert Opin Drug Saf"},{"key":"4263_CR68","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1073\/pnas.1100126108","volume":"108","author":"F Stavru","year":"2011","unstructured":"Stavru, F., Bouillaud, F., Sartori, A., Ricquier, D. & Cossart, P. Listeria monocytogenes transiently alters mitochondrial dynamics during infection. Proc Natl Acad Sci USA \n                           108, 3612\u20133617, doi:10.1073\/pnas.1100126108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"4263_CR69","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1189\/jlb.1112557","volume":"93","author":"N Preyat","year":"2013","unstructured":"Preyat, N. & Leo, O. Sirtuin deacylases: a molecular link between metabolism and immunity. J Leukoc Biol \n                           93, 669\u2013680, doi:10.1189\/jlb.1112557 (2013).","journal-title":"J Leukoc Biol"},{"key":"4263_CR70","doi-asserted-by":"publisher","first-page":"e84481","DOI":"10.1371\/journal.pone.0084481","volume":"8","author":"LE Crotty Alexander","year":"2013","unstructured":"Crotty Alexander, L. E. et al. Myeloid cell sirtuin-1 expression does not alter host immune responses to Gram-negative endotoxemia or Gram-positive bacterial infection. PLoS One \n                           8, e84481, doi:10.1371\/journal.pone.0084481 (2013).","journal-title":"PLoS One"},{"issue":"Suppl","key":"4263_CR71","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.ijantimicag.2013.04.004","volume":"42","author":"E Ciarlo","year":"2013","unstructured":"Ciarlo, E., Savva, A. & Roger, T. Epigenetics in sepsis: targeting histone deacetylases. Int J Antimicrob Agents \n                           42(Suppl), S8\u201312, doi:10.1016\/j.ijantimicag.2013.04.004 (2013).","journal-title":"Int J Antimicrob Agents"},{"key":"4263_CR72","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nri3547","volume":"13","author":"AC Shaw","year":"2013","unstructured":"Shaw, A. C., Goldstein, D. R. & Montgomery, R. R. Age-dependent dysregulation of innate immunity. Nat Rev Immunol \n                           13, 875\u2013887, doi:10.1038\/nri3547 (2013).","journal-title":"Nat Rev Immunol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04263-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04263-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04263-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:40:01Z","timestamp":1671774001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-04263-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["4263"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-04263-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]},"assertion":[{"value":"9 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3853"}}